Citigroup’s China Pharma Holdings CPHI Stock Holding History

Citigroup’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-996	Closed	-$608	–	5810
2026 Q1	$608	Buy	+996	New	+$837	﹤0.01%	5523
2025 Q1	–	Sell	-533	Closed	-$1.24K	–	5657
2024 Q4	$1.24K	Buy	+533	New	+$1.15K	﹤0.01%	5581
2015 Q2	–	Sell	-3	Closed	-$1K	–	7549
2015 Q1	$1K	Buy	+3	New	+$518	﹤0.01%	7034

Other funds holding CPHI

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EFG International Zurich $5.46B AUM

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Citigroup's CPHI Position: Q2 2026 in Review

Citigroup sold out of China Pharma Holdings (CPHI) in Q2 2026, closing a stake of 996 shares — an estimated $608 sold.

Citigroup first reported a position in CPHI in Q1 2015 and held it in 3 quarters. The position peaked at $1.24K in Q4 2024. 8 funds tracked by Wall St. Rank hold CPHI as of Q2 2026.

Citigroup reported no remaining China Pharma Holdings position as of Q2 2026 after selling out during the quarter.
Citigroup sold 996 China Pharma Holdings shares in Q2 2026, an estimated $608.
Citigroup first reported a position in China Pharma Holdings in Q1 2015 and held it in 3 quarters.
Citigroup's China Pharma Holdings position peaked at $1.24K in Q4 2024.
8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.